azacitidine and aminolevulinic acid

azacitidine has been researched along with aminolevulinic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Chen, CT; Lee, MJ; Li, PT; Tsai, YJ1
Chonabayashi, K; Inagaki, A; Kawabata, H; Morimoto, Y; Nagao, M; Nakanishi, K; Narita, M; Nishikawa, M; Okubo, C; Takaori-Kondo, A; Yamasaki-Morita, M; Yoshida, Y1

Other Studies

3 other study(ies) available for azacitidine and aminolevulinic acid

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Increased Histone Deacetylase Activity Involved in the Suppressed Invasion of Cancer Cells Survived from ALA-Mediated Photodynamic Treatment.
    International journal of molecular sciences, 2015, Oct-10, Volume: 16, Issue:10

    Topics: Acetylation; Aminolevulinic Acid; Azacitidine; Cell Line, Tumor; Cell Movement; Chromatin Immunoprecipitation; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Matrix Metalloproteinase 9; MicroRNAs; Mitochondria; Neoplasm Invasiveness; Photochemotherapy; Promoter Regions, Genetic; Proteins

2015
Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia.
    Blood advances, 2022, 02-22, Volume: 6, Issue:4

    Topics: 5-Aminolevulinate Synthetase; Aminolevulinic Acid; Anemia, Sideroblastic; Azacitidine; Female; Genetic Diseases, X-Linked; Humans; Pharmaceutical Preparations; Pyridoxine

2022
chemdatabank.com